Roche's Star MS Drug Snags EU Approval

By January 11, 2018 BioPharma No Comments

The EU approval is based on data from three pivotal Phase III studies from the ORCHESTRA trial programme of 2,388 patients who met primary and nearly all key secondary endpoints.
Source: BioSpace

No announcement available or all announcement expired.